A NEW HOPE FOR WEIGHT REGULATION?

Researchers are excitedly investigating retatrutide, a novel drug developed by Eli Lilly, as a possible step in body loss . Different than many existing approaches, retatrutide is a double -action agonist targeting both GLP-1 and GIP, hormones that impact satiety and blood glucose regulation . Ea